3/25
01:06 pm
mura
Mural Oncology plc (NASDAQ: MURA) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating.
Medium
Report
Mural Oncology plc (NASDAQ: MURA) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating.
3/25
01:06 pm
mura
Mural Oncology plc (NASDAQ: MURA) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating.
Medium
Report
Mural Oncology plc (NASDAQ: MURA) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating.
3/25
12:56 pm
mura
Mural Oncology downgraded to Equal Weight from Overweight at Morgan Stanley
Medium
Report
Mural Oncology downgraded to Equal Weight from Overweight at Morgan Stanley
3/25
12:56 pm
mura
Mural Oncology downgraded to Equal Weight from Overweight at Morgan Stanley
Medium
Report
Mural Oncology downgraded to Equal Weight from Overweight at Morgan Stanley
3/25
12:18 pm
mura
Mural Oncology plc (NASDAQ: MURA) was downgraded by analysts at Raymond James from a "strong-buy" rating to an "outperform" rating. They now have a $18.00 price target on the stock.
Low
Report
Mural Oncology plc (NASDAQ: MURA) was downgraded by analysts at Raymond James from a "strong-buy" rating to an "outperform" rating. They now have a $18.00 price target on the stock.
3/25
12:18 pm
mura
Mural Oncology plc (NASDAQ: MURA) was downgraded by analysts at Raymond James from a "strong-buy" rating to an "outperform" rating. They now have a $18.00 price target on the stock.
Low
Report
Mural Oncology plc (NASDAQ: MURA) was downgraded by analysts at Raymond James from a "strong-buy" rating to an "outperform" rating. They now have a $18.00 price target on the stock.
3/25
11:39 am
mura
Mural Oncology downgraded to Outperform from Strong Buy at Raymond James
Medium
Report
Mural Oncology downgraded to Outperform from Strong Buy at Raymond James
3/25
11:39 am
mura
Mural Oncology downgraded to Outperform from Strong Buy at Raymond James
Medium
Report
Mural Oncology downgraded to Outperform from Strong Buy at Raymond James
3/12
08:05 am
mura
Mural Oncology plc (NASDAQ: MURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Low
Report
Mural Oncology plc (NASDAQ: MURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.